Back to Archive
October 17, 2025

📊 Market Rallies | Fed Signals Rate Pause

🎯 TL;DR

DOWN (LBRT) — Energy company recovering near 52-week lows; watch partnership news for growth signs. | IRON — Biotech firm with promising drugs and strong recent gains; good for growth if you can handle ups and downs. | PRAX — High-risk biotech focused on brain disorders, big swings but potential big rewards around $45–$55.

📊 Today's Stocks at a Glance

🔹 LBRT

Energy

Track Record

What it does

Liberty Energy offers services like hydraulic fracturing to help produce oil and gas more efficiently. The stock is near a 52-week low after falling off recent highs.

Why it matters today

This stock is cheaper than before because the market feels uncertain about energy prices and new projects.

Price

$11.94

Action

BUY

Stop Loss

Pro

Profit Target

Pro

Risk/Reward Ratio: 1:2.0

🧭What to Do: Hold for now and watch how the Oklo partnership develops; consider buying if price stabilizes near $10.50–$12.50.

Why this matters to you

Cooling off

Risk level: MediumConfidence:Pro

🔹 IRON

Healthcare

Track Record

What it does

IRON works on new drugs targeting blood diseases. The stock has grown about 47% over the past year, fueled by hope around its drug pipeline.

Why it matters today

This stock's price goes up and down a lot because the company isn't making profits yet.

Price

$75.34

Action

BUY

Stop Loss

Pro

Profit Target

Pro

Risk/Reward Ratio: 1:2.0

🧭What to Do: Consider buying if comfortable with risk, especially on dips near $65–$72 before earnings.

Why this matters to you

Uptrend with volatility

Risk level: MediumConfidence:Pro

🔹 PRAX

Healthcare

Track Record

What it does

PRAX develops targeted medicines for disorders like epilepsy affecting the brain's nervous system. The stock soared over 140% last year but is very volatile now.

Why it matters today

This stock is risky because it depends on whether new medicines get approved.

Price

$52.52

Action

BUY

Stop Loss

Pro

Profit Target

Pro

Risk/Reward Ratio: 1:2.0

🧭What to Do: Watch for key news like clinical trial results; consider buying only if price dips into $45–$55 range and you can handle risk.

Why this matters to you

Volatile / speculative

Risk level: HighConfidence:Pro

Pro Features

Unlock Full Analysis

Free readers see a limited version of this brief. Pro members unlock confidence scores, stop-loss levels, profit targets, and complete position sizing recommendations across the full archive.

Starting at $8/month60-day guarantee

Share this brief

Help others discover Daily Ticker

Get daily briefs

Receive market insights every morning at 8 AM EST